Oncternal Therapeutics (ONCT) Q3 2023 Earnings

Nov 9Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.21
-0.19
-0.16
-0.14

Details

Expected EPS
-0.14
Actual EPS
-0.17
Surprise EPS
-0.03
Surprise Percent
-21.43%

Description

⁨Oncternal Therapeutics⁩ (⁦ONCT⁩) has reported earnings of ⁦-0.17⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts